34.81
+0.715(+2.10%)
Currency In USD
Address
21 Hickory Drive Suite 500
Waltham, MA 02451
United States of America
Phone
617 819 2020
Website
Sector
Healthcare
Industry
Biotechnology
Employees
41
First IPO Date
February 07, 2025
| Name | Title | Pay | Year Born |
| Michael Cloonan | President, Chief Executive Officer & Director | 784,593 | 1971 |
| Charlotte McKee | Chief Medical Officer | 647,922 | 1965 |
| Elena H. Ridloff | Chief Financial Officer | 647,922 | 1980 |
| Greg Hurlbut | Co-Founder & Senior VP of Discovery Research | 0 | N/A |
| Mark Munson | Co-founder & Senior Vice President of Medicinal Chemistry | 0 | N/A |
| Andy Chu | Vice President of Information & Technology | 0 | N/A |
| Jennifer Fitzpatrick | Chief Legal Officer | 0 | 1977 |
| Mara Furlow | Senior Vice President of Global Regulatory Affairs & Quality | 0 | N/A |
| Meghan Bagshaw | Vice President of Programs, Portfolio & Operations | 0 | N/A |
| Vanya Sagar | Chief People Officer | 0 | 1976 |
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.